Iterum Therapeutics plc Recorded Big Gain

Iterum Therapeutics plc (ITRM:NASDAQ) rocketted at $0.82, a gain of 42.6%. On Mon 23 Nov 20, ITRM:NASDAQ touched a New 2-Week High of $0.58. The stock got featured on our News Catalysts scanner on Mon 16 Nov 20 at 08:01 AM in the 'EARNINGS' category. From Mon 09 Nov 20, the stock recorded 60.00% Up Days and 72.73% Green Days
The stock spiked on Wed 30 Sep 20 at $2.44 with a volume of 212M+, and its share price has been moving sideways in recent weeks.
About Iterum Therapeutics plc (ITRM:NASDAQ)
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
Top 10 Gainers:
- ECMOHO Limited (MOHO:NASDAQ), 151.75%
- Fuel Tech, Inc. (FTEK:NASDAQ), 114.18%
- VACQ (VACQ:NASDAQ), 100%
- Yunji Inc. (YJ:NASDAQ), 90.67%
- The Goldfield Corporation (GV:NYSEMKT), 63.23%
- Camber Energy, Inc. (CEI:NYSEMKT), 48.73%
- Luokung Technology Corp. (LKCO:NASDAQ), 46.02%
- Iterum Therapeutics plc (ITRM:NASDAQ), 42.61%
- Ocean Power Technologies, Inc. (OPTT:NASDAQ), 39.17%
- ENGlobal Corporation (ENG:NASDAQ), 38.16%